U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148323) titled 'HemoSphere Alta Study' on Aug. 13. Brief Summary: A prospective, non-randomized single arm... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147608) titled 'SAPHIR2 : Simplification of PHysical Activity Assessment by Rapid Interrogation' on Aug. 21... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07149038) titled 'Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascul... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148739) titled 'Ensuring Access to Optimal Therapy in CF: The ENACT Study' on May 02. Brief Summary: This ... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07149155) titled 'Adaptation of SFA for HRW' on Aug. 18. Brief Summary: The aim of this study is to pilot an... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148102) titled 'Diaphragmatic Ultrasound and Thoracic Fluid Content for Prediction of Non-Invasive Ventilat... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07149142) titled 'Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabete... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147257) titled 'A Trial to Assess the Pharmacokinetic Similarity Between CHS-1420 40 mg/0.4 mL and HUMIRA(R... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147816) titled 'Cervical Transcutaneous SCS for TBI' on Aug. 20. Brief Summary: The goal of this study is ... Read More
U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147361) titled 'Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma' on Aug. 14. ... Read More